Lance Conrad - Investview VP Sales

All Insiders . USA . 
Stock . Investview . Stakeholders . Insider . Lance Conrad
INVU Stock  USD 0.02  0.0005  2.13%   

Insider

Lance Conrad is VP Sales of Investview
Phone732 889 4300
Webhttps://investview.com

Investview Management Efficiency

The company has return on total asset (ROA) of 0.5497 % which means that it generated a profit of $0.5497 on every $100 spent on assets. This is way below average. Investview's management efficiency ratios could be used to measure how well Investview manages its routine affairs as well as how well it operates its assets and liabilities.
Investview currently holds 11.97 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. Investview has a current ratio of 2.15, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Investview until it has trouble settling it off, either with new capital or with free cash flow. So, Investview's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Investview sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Investview to invest in growth at high rates of return. When we think about Investview's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Annie MackAkari Therapeutics PLC
N/A
Todd MBAArmata Pharmaceuticals
61
MBA MRAerovate Therapeutics
62
Joseph CPAInhibikase Therapeutics
62
Rex CFAAnebulo Pharmaceuticals
64
Surendra SinghInhibikase Therapeutics
N/A
Prof JavittNRx Pharmaceuticals
N/A
Hunter MDAerovate Therapeutics
59
Michael KunzNRx Pharmaceuticals
59
Robert FloydProcessa Pharmaceuticals
68
Miles NunnAkari Therapeutics PLC
56
Torsten HombeckAkari Therapeutics PLC
54
Ray MDAkari Therapeutics PLC
79
Anne MoonTempest Therapeutics
N/A
MPH MDNRx Pharmaceuticals
68
RAC SakaiTempest Therapeutics
N/A
George EldridgeAerovate Therapeutics
62
Philip LavinNRx Pharmaceuticals
78
Petpiboon PrasitTempest Therapeutics
N/A
BSc FRCPCInhibikase Therapeutics
N/A
Donna DeaAerovate Therapeutics
N/A
Investview, Inc., through its subsidiaries, delivers financial education, digital assets, and related technology for individuals. Investview, Inc. was incorporated in 1946 and is headquartered in Eatontown, New Jersey. Investview operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 33 people. Investview [INVU] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Return On Asset0.55

Investview Leadership Team

Elected by the shareholders, the Investview's board of directors comprises two types of representatives: Investview inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Investview. The board's role is to monitor Investview's management team and ensure that shareholders' interests are well served. Investview's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Investview's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Bell, COO Pres
Lance Conrad, VP Sales
Victor Oviedo, CEO Director
Annette Raynor, Strategic Advisor
Jayme McWidener, Chief Officer
Chad Garner, Pres LLC
Mario Romano, Treasurer, Director of Finance and Investor Relations
Ralph CPA, Chief Officer

Investview Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Investview a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset0.55
Profit Margin(0.1) %
Operating Margin(0.71) %
Current Valuation26.51 M
Shares Outstanding2.64 B
Shares Owned By Insiders88.00 %
Price To Earning1.78 X
Price To Book1.09 X
Price To Sales0.42 X
Revenue77.77 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Investview OTC Stock Analysis

When running Investview's price analysis, check to measure Investview's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Investview is operating at the current time. Most of Investview's value examination focuses on studying past and present price action to predict the probability of Investview's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Investview's price. Additionally, you may evaluate how the addition of Investview to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY